Laurus Labs Limited has informed the Exchange about Schedule of meet
LAURUSLABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Laurus Labs has announced a conference call to discuss its Q1 FY26 (April-June 2025) results, scheduled for Friday, July 25, 2025 at 5:00 PM IST. The call will be hosted by DAM Capital Advisors and will be followed by an interactive Q&A session with investors and analysts. Dial-in numbers have been provided for participants in India, Singapore, Hong Kong, USA, and UK. Laurus Labs is a research-driven pharmaceutical and biotech company with leadership in APIs (Anti-retroviral, Oncology, Cardiovascular, Gastro) and growing CMO/CDMO services, reporting FY25 revenue of ₹5,554 crore.
This is a routine advance notice for the upcoming earnings call, signalling that Q1 FY26 results will be released on or around July 25, 2025. Investors should watch for actual results and management commentary on that date for any stock-moving news.